These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20496989)

  • 1. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
    Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
    Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.
    Li M; Gao C; Li H; Wang Z; Cao Y; Huang W; Li X; Wang S; Yu L; Da W
    Med Oncol; 2011 Sep; 28(3):840-5. PubMed ID: 20414818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five
    Vittayawacharin P; Khuhapinant A
    Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.
    Yokoyama H; Yamada MF; Ishizawa K; Yamamoto J; Tomiya Y; Harigae H; Kameoka J; Ichinohasama R; Sasaki T
    Tohoku J Exp Med; 2007 Apr; 211(4):395-9. PubMed ID: 17409680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine.
    Yuan L; Sun L; Bo J; Zhou Y; Li HH; Yu L; Gao CJ
    Ann Transplant; 2011; 16(3):135-8. PubMed ID: 21959522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].
    Yuan FF; Yin QS; Fu YW; Wang Q; Chen L; Mi RH; Li YF; Wei XD; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):569-572. PubMed ID: 30122016
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
    Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
    Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.
    Jeong SH; Song HN; Park JS; Yang DH; Koh Y; Yoon SS; Lee HW; Eom HS; Won JH; Kim WS; Kim SJ
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2471-2478. PubMed ID: 30064012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
    Wang J; Wei L; Ye J; Yang L; Li X; Cong J; Yao N; Cui X; Wu Y; Ding J; Zhang L
    Int J Hematol; 2018 Jan; 107(1):98-104. PubMed ID: 28856590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
    Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
    Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Philippe Walter L; Couronné L; Jais JP; Nguyen PD; Blaise D; Pigneux A; Socié G; Thieblemont C; Bachy E; Fegueux N; Chevallier P; Mohty M; Yakoub-Agha I; Peffault de Latour R; Jaccard A; Hermine O;
    Am J Hematol; 2021 Jul; 96(7):834-845. PubMed ID: 33864708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
    Ennishi D; Maeda Y; Fujii N; Kondo E; Shinagawa K; Ikeda K; Ichimura K; Yoshino T; Tanimoto M
    Leuk Lymphoma; 2011 Jul; 52(7):1255-61. PubMed ID: 21599584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
    Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
    Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.